CDP-choline circumvents mercury-induced mitochondrial damage and renal dysfunction

Area of Science:

• Biochemistry
• Toxicology
• Nephrology

Background:

• Heavy metal ions, such as mercury (Hg²⁺), can cause significant kidney damage and lead to renal failure.
• Mitochondrial dysfunction and oxidative stress are key mechanisms in heavy metal-induced nephrotoxicity.

Purpose of the Study:

• To investigate the protective effects of CDP-choline against Hg²⁺-induced kidney damage.
• To elucidate the mechanisms underlying CDP-choline's protective action at the mitochondrial level.

Main Methods:

• Administration of Hg²⁺ and CDP-choline to study subjects.
• Assessment of mitochondrial function, including matrix content retention, transmembrane electric gradient, hydrogen peroxide generation, and TBARS.
• Evaluation of oxidative damage to mitochondrial DNA (mtDNA).
• Measurement of inflammatory markers (IL-1, IL-6) and renal function markers (creatinine clearance, BUN, serum creatinine).

Main Results:

• CDP-choline (125 mg/kg) administration prevented Hg²⁺ (3 mg/kg)-induced kidney damage.
• CDP-choline preserved mitochondrial integrity by maintaining Ca²⁺ retention, transmembrane electric gradient, and reducing hydrogen peroxide and TBARS.
• CDP-choline protected mtDNA from oxidative damage and inhibited the release of IL-1 and IL-6.
• Renal function markers, including creatinine clearance, BUN, and serum creatinine, remained near normal in CDP-choline treated subjects.

Conclusions:

• CDP-choline exhibits significant protective effects against Hg²⁺-induced nephrotoxicity.
• The protective mechanism involves safeguarding mitochondrial function and reducing oxidative stress and inflammation.
• CDP-choline represents a potential therapeutic agent for mitigating heavy metal-induced kidney injury.